Dasantha Jayamanne | DJ |
@DasanthaJ
Followers
246
Following
1K
Media
7
Statuses
63
Radiation Oncologist Sydney RNSH | Lung | CNS | Head & Neck | views are my own
St Leonards, Sydney
Joined October 2019
Excited to present at #ASTRO24 on #sim_free #radiotherapy for #palliative pts. We will share #real_world insights into this exciting paradigm from *1000* routine care courses...🇦🇺 👉SS 05 - Pall 1 Session 📅Sun, Sep 29 ⏰ 3:15 – 3:25 PM ET 📍Room 151 @ASTRO_org @NthSydHealth
5
8
45
🚨📢Happening now - HN oral abstracts #ASCO24‼️ PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by @imrtlee @MSK_RadOnc @MSKCancerCenter, showing that 30Gy+Chemo is sufficient for cure, with > 500 pts treated so far.
10
79
172
PACIFIC regimen improves OS for LA-NSCLC and now LS-SCLC. #radonc @QuadShotNews
🔥🚨@OncoAlert Hot Off the Press BIG NEWS Press Release by @AstraZeneca
#ADRIATIC phase 3 trial of #Durvalumab vs #Placebo after concurrent chemoradiotherapy in pts with limited-stage #SmallCell #LungCancer met dual primary endpoints of ⬆️#OS & ⬆️#PFS 👇🏼 https://t.co/DAEapPYsZ7
3
24
66
1/N Finally out!! -- 30Gy for HPV+OPC in @JCO_ASCO – work by the @MSKCancerCenter Head and Neck team, led by @imrtlee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc #hncsm
ascopubs.org
PURPOSEStandard curative-intent chemoradiotherapy for human papillomavirus (HPV)–related oropharyngeal carcinoma results in significant toxicity. Since hypoxic tumors are radioresistant, we posited...
26
122
297
Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ @IASLC
@MDAndersonNews @TheLancet @ACKoongMDPhD
@StephenVLiu
17
191
461
Fantastic talk by @shalinivinod13 ! A great summary of thoracic RT for SCLC. #RANZCR2022 see the publication here—> https://t.co/gAEsP2U4HH
0
2
19
Another powerful talk by @DrewMoghanaki on RWE for stage III inoperable NSCLC - exciting times ahead in the IO era! Reminding us that patient focus is always key. #RANZCR2022 @shalinivinod13
1
3
28
Please join for expert teaching session on volume delineation #LCSM by FROLIC @RANZCRcollege RANZCR2021 16th September 1:30-3 AEST @DasanthaJ @RadOncDoc_Gee @JaneLudbrook
0
2
5
Great discussion regarding best fractionation in LS SCLC by Prof Vinod @shalinivinod13 @TOGAANZ
0
2
10
Looking forward to inaugural TOGA meeting to discuss #lungcancer updates from #ESMO20 . @DrMelMoore @victoriajbray @drprunellab @Eric73363938 @RadOncDoc_Gee @gerryhanna
1
7
22
Great wrap of lung cancer from #Asco2020 by these big hitters! #ALTGonASCO20 #altg @Mal_Itchins @TommyJohn00 @perth_meso_dr @MeganSa31833581
0
0
5
We treated a head and neck patient who had significant weight loss @CGlideHurst.
0
0
1
#EXCLUSIVE: Today marks a new frontier in one of the main pillars of cancer treatment, thanks to the use of more advanced radiation therapy technology. @gabyrogers #9News
0
12
19
NSCC treating the first patient in the country with adaptive RT on Ethos. Amazing team effort! #adaptiveRT #personalisedoncology #ethos #nscc #radiationoncology
3
3
13